Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S259410, C514S267000, C544S250000, C544S252000, C544S282000
Reexamination Certificate
active
06875771
ABSTRACT:
Novel pyridopyrimidine derivatives which have a binding affinity for the human 5-HT6receptor and, therefore, are useful in treating disorders responsive to antagonism of the 5-HT6receptor such as psychosis, schizophrenia, manic depression, depression, neurological disorder, memory disorder, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's chorea.
REFERENCES:
patent: 5990105 (1999-11-01), Bös et al.
patent: 6441013 (2002-08-01), Greiner et al.
patent: 0 930 302 (1999-07-01), None
patent: 0 941 994 (1999-09-01), None
patent: WO 0037452 (2000-06-01), None
Huggins, Serotonin Receptors and the Effects of Ecstasy, Stanislaus Journal of Biochemical Reviews, May 2001.*
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-1996, 1996.*
Layzer, Degenerative Diseases of the Nervous System, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 2050-2057, 1996.*
Bentley, J. C., et al.,British J. Pharm.(1999) 126:1537-1542.
Bourson, A. et al.,J. Pharmacol. Exp. Ther.(1995) 274(1):173-180.
Monsma, F. J. et al.,Mol. Pharmacol. (1993) 43:320-327.
Murata, S. et al.,British J. of Pharmocol. (1999) 127:19-26.
Rogers, D.C. and Hagan J.J.,Psychopharmacology(2001) 158:114-119.
Roth, B. L. et al.,J. Pharmacol. Exp. Ther. (1994) 268(3):1403-1410.
Sleight, A. J. et al.Behav. Brain Res. (1996) 73: 245-248.
Ward, R. P. et al.,Neuroscience(1995) 64(4):1105-1111.
Woolley, M.L. et al.,Neuropharmacology(2001) 41:210-219.
Grant-Young Katharine A.
Hu Shuanghua
Huang Yazhong
Scola Paul M.
Wu Yong-Jin
Algieri Aldo A.
Bristol--Myers Squibb Company
Rao Deepak
LandOfFree
Pyridopyrimidine derivatives as 5-HT6 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridopyrimidine derivatives as 5-HT6 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridopyrimidine derivatives as 5-HT6 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3412432